MedPath

Sex chromosome abnormality as co-finding when performing routine prenatal diagnostic procedures: diagnostic gain or damage? Study on the views of parents and professionals.

Conditions
foetale geslachtsbepaling
gender determination
10083624
Registration Number
NL-OMON31988
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Parents that have undergone an invasive prenatal diagnostic test in the last 15 years in the Nijmegen region because of maternal age or to exclude other serious chromosomal anomalies, who were faced with a fetal sex chromosomal abnormality as a co-finding in the karyotyping procedure.

Exclusion Criteria

. Patients with a clear risk at a sex chromosomal abnormality, because of an earlier child with this same problem.
. Patients with insufficient fluency in Dutch.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1.Did these parents desire to know the fetal sex after amniocenteses in week 15<br /><br>of the pregnancy?<br /><br><br /><br>2.Were these parents willing to wait 4 weeks to know the fetal sex when sex<br /><br>determination would be performed by ultrasound examination in week 20 of the<br /><br>pregnancy?<br /><br><br /><br>3.How have they experienced the consequences of the diagnosis of a<br /><br>sexchromosomal abnormality during routine prenatal diagnostic testing?<br /><br><br /><br>4.How do they look back on the events and how is their general quality of life<br /><br>at this moment?<br /><br><br /><br>5. What is the opinion about this specific problem of the professionals<br /><br>involved?</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Factors associated with the parents* desire to know the sex of their baby.<br /><br>(ref Shipp, 2004)</p><br>
© Copyright 2025. All Rights Reserved by MedPath